 |
| Business is Booming for BICX and BMIX Bounces Back Up a Second Day |
|
 Hot Stock to Watch
|
Company: BioCorRx Inc. (OTCQB: BICX)
|
End of Day:
Price: 0.109
Change (%): + 0.0061 (5.93)
Volume: 20,800 |
 |
BioCorRx, Inc. Announces 111% Increase in Patients Treated with Start Fresh Program and Upcoming Shareholder Conference Call
Los Angeles, Sept. 17, 2014 (GLOBE NEWSWIRE) - BioCorRx, Inc. (BICX), a leader in addiction treatment, announces a 111% increase in patients being treated with its Start Fresh Program since July 2014 by independent clinics. The Company believes the increase is due to significant national expansion and branding efforts over the course of the year to date. In 2014 BioCorRx, Inc. secured license agreements for ten additional states and direct distribution deals with clinics in two other states owned by Dr. George Fallieras. Currently, there are nine clinics open serving patients using the Start Fresh Program, compared to just one operating clinic this time last year. By year-end, at least three new clinics should be opening according to information provided to the company by licensees and Dr. Fallieras. “We are pleased to see an increase of this magnitude, this is not only impactful for the financials of BioCorRx, Inc. but also for the families receiving the effective help they need to get them on the road to recovery” stated CEO Kent Emry.
Continue Reading
|
 Yesterday's Top Performer
|
Company: Brazil Minerals Inc. (OTCQB: BMIX)
|
End of Day:
Price: 0.0558
Change (%): + 0.0029 (5.48)
Volume: 639,342 |
 |
Goldman Small Cap Research Issues Research Report on Brazil Minerals, Inc.
BALTIMORE, Sept. 16, 2014 /PRNewswire/ -- Goldman Small Cap Research, a stock market research firm focused on the small cap and micro cap sectors, announced today that it has released a new research report on Brazil Minerals, Inc. (OTCQB: - BMIX), a pure play on the huge Brazilian natural resources space and the only publicly-traded diamond and gold company from Brazil.
Continue Reading |
SmallCapVoice Clients' News
|
Company: PositiveID Corporation (OTCQB: PSID)
|
Initiate Coverage Of PositiveID Corporation With A SPECULATIVE BUY Rating And A $0. 14 Price Target
PSID operates in the large, rapidly growing bio-threat detection market. Its lead product directly addresses this market, which has seen a surge in funding over the past decade. This is attributed to the Anthrax scare in 2001, the ricin letters in 2004, the 2003 SARS and 2009 H1N1 health crises, and most recently the concern over Middle East and North Korean chemical/biological weapons. These events have confirmed that tangible threats of infectious disease and bioterrorism. This is reiterated by significant grant money allocated by the US government. The annual global bio-detection market is growing at 12% annually and is expected to reach 5.6 billion dollars by 2016 in the US.
Continue Reading
|
Company: Medical Marijuana Inc. (Pink Sheets: MJNA)
|
Cannabis for Consumers... and Pets: Medical Marijuana Inc.'s HempMeds Unveils New CBD-Rich Products at Natural Products Expo East
HempMeds Introduces Advances in Cannabis Industry at Largest East Coast Natural Products Buyer Trade Show, Details Explained at Hosted Education Session and Samples Provided
SAN DIEGO, Sept. 16, 2014 (GLOBE NEWSWIRE) - Medical Marijuana Inc.’s (OTC Pink:MJNA) HempMeds™ - a corporate portfolio company of Medical Marijuana Inc. and the exclusive master distributor and contracted marketing company for Medical Marijuana, Inc. - is proud to sponsor Natural Products Expo East. HempMeds™, a pioneer of cannabidiol (CBD)-rich (hemp) cannabis products, is exhibiting from booth #4215 and will reach an estimated 25,000 natural product buyers during the two-day expo.
Continue Reading |
Other Small Cap News
|
Company: Advanced Medical Isotope Corporation (OTCQB: ADMD)
|
Advanced Medical Isotope Corporation Licensed Brachytherapy Seed Patent Granted
KENNEWICK, Wash., Sept. 16, 2014 /PRNewswire/ -- Advanced Medical Isotope Corporation ("AMIC") (OTCQB: ADMD), a late stage development company engaged primarily in the development of brachytherapy devices and medical isotopes for diagnostic and therapeutic applications, today announced that a patent was awarded for technology related to its brachytherapy products. AMIC's rights for the newly issued patent arise from its license from Battelle, under which AMIC exclusively licensed technologies developed at Pacific Northwest National Laboratory and the University of Utah for its proposed brachytherapy products. The patent awarded, US 8,821,364 B2, relates to AMIC's brachytherapy seed product and is entitled: Brachytherapy Seed with Fast Dissolving Matrix for Optimal Delivery of Radionuclides to Cancer Tissue. AMIC will support Battelle in further patent protection for additional markets consistent with AMIC's overall global commercialization strategy.
Continue Reading |
Market News
|
By Peter Schacknow: CNBC
|
Early movers: MSFT, BA, LEN, FDX, AUXL, CS & more Peter Schacknow
Check out which companies are making headlines before the bell:
FedEx - The shipping giant earned $2.10 per share for its first quarter, beating estimates of $1.96, while revenue also beat consensus. Separately, FedEx is raising its U.S. shipping rates by an average of 4.9 percent in January.
Lennar - The home builder earned 78 cents per share for its third quarter, nine cents above estimates, with revenue also above forecasts. Lennar's quarter was fueled by a surge in new orders.
Continue Reading
|
By Lee Brodie: CNBC
|
Here's what Cramer's watching for from the Fed
Only three things matter to the market right now; the Fed, the Fed and the Fed.
Cramer is hoping in its statement on Wednesday that the Federal Reserve effectively says, "Yes, we're winding down our bond buying program, but we recognize that recent employment figures have not been strong and the rest of the world is weaker, so we must stay vigilant to keep the economy on a growth track."
That's just one of the things that Cramer says "needs to go right to get the market beyond these levels." What else needs to go right?
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the "unsubscribe" link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
